SBC Medical Group Holdings Incorporated
SBC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $43 | $43 | $47 | $44 |
| % Growth | -0% | -8.4% | 6.5% | – |
| Cost of Goods Sold | $13 | $13 | $10 | $11 |
| Gross Profit | $30 | $30 | $38 | $34 |
| % Margin | 69% | 69.2% | 79.7% | 76.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $13 | $12 | $13 |
| SG&A Expenses | $14 | $14 | $13 | $14 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $1 | $1 | $15 |
| Operating Expenses | $14 | $15 | $14 | $29 |
| Operating Income | $16 | $15 | $24 | $5 |
| % Margin | 36.6% | 33.6% | 51.1% | 10.6% |
| Other Income/Exp. Net | $3 | -$1 | $7 | $1 |
| Pre-Tax Income | $19 | $14 | $31 | $6 |
| Tax Expense | $6 | $11 | $10 | -$0 |
| Net Income | $13 | $2 | $22 | $7 |
| % Margin | 29.6% | 5.7% | 45.4% | 14.7% |
| EPS | 0.125 | 0.024 | 0.208 | 0.064 |
| % Growth | 424.8% | -88.6% | 227.4% | – |
| EPS Diluted | 0.125 | 0.024 | 0.208 | 0.064 |
| Weighted Avg Shares Out | 103 | 104 | 103 | 103 |
| Weighted Avg Shares Out Dil | 103 | 104 | 103 | 103 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $19 | $14 | $32 | $7 |
| % Margin | 44.4% | 32.8% | 67.8% | 15.8% |